• Head & neck cancer (oral, NPC, oropharyngeal)

• Inpatients undergoing surgery/RT/chemo

• Radiation-induced oral mucositis & skin

• Post-chemo cytopenia & cancer fatigue

• Endstage cachexia & cancer pain

Established in 2006, Chang Gung Taoyuan TCM Department launched Taiwan's first TCM cancer ward (50 beds), integrating Eastern-Western medicine for cancer care. Multiple SNQ, National Biotech Quality Award, MOEA Solidarity Circle, and MOHW Jade Step Award honors. The team includes 20 attending physicians, 18 residents, 10 nurses, and 20 TCM pharmacists across Internal/Pediatrics, Acupuncture, Gynecology, ward, and pharmacy. Head & neck care follows a standardized flow: baseline assessment → TCM intervention → progress evaluation, with EORTC and CTCAE tracking. Innovative formulae include Tseng-Yi-Tang gargle, Gan-Lu-Yin, Chui-Hou-San for radiation mucositis; Bai-Zhi-Aloe gel for radiation dermatitis; Ren-Shen-Yang-Rong-Tang & Gui-Lu-Er-Hsien-Jiao for cytopenia; acupuncture (Baihui, Hegu) for cancer fatigue; herbal hot-pack for chronic pain. NPC 5-year survival 78.9%, significantly higher than China, EU, USA, India benchmarks.

• Taiwan's 1st TCM ward (50 beds, 2006)

• Multimodal East-West integrated model

• One-stop inpatient/OPD TCM cancer care

• Multidisciplinary case meetings

• Innovative TCM (gargles, gels, ointments)

• NPC survival rate among top globally

• 20 attending physicians, 18 residents

• 50-bed TCM ward

• 2024 OPD 5,712 / inpatient 2,481

• Pilot Program for Hospitalization of Western Medicine Cancer Patients with Traditional Chinese Medicine: 439

• Other non-traditional Chinese medicine pilot programs for hospitalization: 641

• 20 TCM pharmacists, 15 nurses

• NPC 3-year survival: 85.5%

• NPC 5-year survival: 78.9%

• Higher than China 56.1%, EU 56.7%

• Higher than US NCDB 63.4%

• Higher than Malaysia, India, Czech

• 5 TCM SCI papers (4 in past 5 yrs)

• Standardized EORTC tracking

• CTCAE adverse event evaluation

• Safety review of TCM prescriptions

• Pharmacist dispensing & monitoring

• Cross-team efficacy meetings

• TCM ward nursing guidelines

• Significant dry-mouth relief late in course

• Reduced side effects, improved QoL

• PTS evening news endorsement

• Discovery Channel feature

• High follow-up retention

• Patient & family appreciation letters

• 13 papers (2012-2025, 4 SCI)

• 9 research projects (NT$9.7M)

• 70 intl trainees from 9 countries (2023-25)

• 267 intl visitors from 15 countries

• Collaboration: US, Singapore, Malaysia

• Discovery Channel "Health Equity in Taiwan" feature

• 2021 SNQ National Quality Mark

• 2022 MOHW Yujie Award-Excellence Award

• 2021 SNQ Top Healthcare Team

• 2012 National Biotech Quality Silver

• MOEA Solidarity Circle (multiple years)

• Improves H&N cancer survival & QoL